Tuberculosis is a serious lung infection caused by a germ called Mycobacterium tuberculosis. It can also affect other parts of the body, like the kidneys or spine. It's spread through tiny droplets from the air when someone with TB coughs or sneezes.
Every report comes from a Lived member, sent anonymously.
Have you tried Isoniazid for Tuberculosis?
Tuberculosis (TB) is an infection caused by the bacterium Mycobacterium tuberculosis. It most often affects the lungs, but it can also damage other parts of the body, including the kidneys, spine and brain. TB disease can almost always be cured with the right antibiotics, but without proper treatment it can be fatal. Being infected with TB germs is not the same as being sick with TB. In inactive (latent) TB infection, the immune system keeps the bacteria in check: the person feels well, has no symptoms and cannot spread TB to anyone. In active TB disease, the bacteria are multiplying and causing illness. Typical symptoms include a cough lasting three weeks or longer, sometimes with blood or thick mucus, along with fever, night sweats, tiredness, loss of appetite and weight loss without trying. Someone with active TB in the lungs or throat can pass it to others.
TB spreads through the air. When a person with active TB in the lungs or throat coughs, sneezes, talks or sings, others nearby can breathe in the bacteria. Spread is most likely indoors and among people who share space for long periods, such as household members and coworkers. TB does not spread through touching, kissing or sharing food and dishes. The chance of being exposed is higher for people who were born in or often travel to countries where TB is common, health care workers, and people who live or work in shelters, jails or nursing homes. Once infected, most people never become sick. Inactive infection is more likely to turn into active disease when the immune system is weakened, for example by HIV, diabetes or cancer, or by medicines that suppress the immune system, such as steroids, drugs taken after an organ transplant and some treatments for autoimmune conditions. Risk is also higher in the first two years after infection, in children under 5, in older adults, in people who inject drugs or have alcohol use disorder, and in people whose earlier TB treatment was incomplete.
Testing usually happens in two steps. The first asks whether TB germs are in the body at all. This is done with either a TB blood test or a TB skin test, in which a small amount of test material is placed under the skin of the forearm and the reaction is checked a few days later. The BCG vaccine (bacille Calmette-Guérin, a TB vaccine given to children in many countries) can affect the skin test, so the blood test is preferred for people who received it. A positive result shows infection but cannot tell inactive TB from active disease. The second step answers that question. A chest X-ray looks for signs of disease in the lungs, and samples of sputum (mucus coughed up from the lungs) are examined and grown in a laboratory to look for the bacteria. Those lab tests also show which medicines the bacteria respond to, which guides treatment. When TB may be outside the lungs, urine or tissue samples may be tested instead.
TB is treated with several antibiotics taken together, because a single drug lets resistant bacteria survive. Inactive TB is treated to prevent it from ever becoming active disease. The preferred options are short courses built around rifampin or rifapentine (rifamycin antibiotics): for example, a weekly dose of isoniazid plus rifapentine for three months, or daily rifampin for four months. Longer courses of isoniazid alone are an alternative. Active disease must be ruled out first, since treating it with a preventive regimen would not be enough. Active TB disease usually takes four to six months of treatment and sometimes longer. A standard course starts with four medicines (isoniazid, rifampin, pyrazinamide and ethambutol) for two months, then continues with two of them. For people 12 and older with TB in the lungs that responds to the usual drugs, a four-month regimen that adds moxifloxacin and uses rifapentine is another option. Many children with milder TB can also finish in four months. Drug-resistant TB, in which the bacteria no longer respond to key medicines, is treated by TB specialists with different combinations, such as bedaquiline, pretomanid and linezolid for about six months. People usually start feeling better within weeks, but the bacteria are not gone yet. Missing doses or stopping early can bring the illness back and allow the bacteria to become resistant, which makes TB much harder to treat. Many health departments offer directly observed therapy, in which a health care worker meets with the person, in person or by video, to confirm each dose. Rifampin and rifapentine interact with many other medicines and make hormonal birth control unreliable, so people using it are advised to add or switch to a barrier method. These drugs also turn urine, sweat and tears orange, which is harmless.
Most people with active TB recover fully when they complete treatment. The months of daily or weekly medicines can be demanding, and side effects such as nausea or tiredness are common reasons people struggle to keep going, so it helps to raise problems with the care team rather than skipping doses. Regular check-ins track how treatment is going, and for lung TB, repeat sputum tests show when the bacteria have cleared. Because active TB in the lungs can spread, people may need to stay away from work, school or other people for a time early in treatment, as directed by their care team or the local health department. The health department usually also contacts household members and other close contacts so they can be tested. For inactive TB, there are no symptoms to improve, so the benefit of treatment is protection against becoming sick later. Finishing treatment clears the bacteria already in the body, but it does not prevent a new infection after future exposure.
Ask about TB testing if you have a cough lasting three weeks or longer, especially with fever, night sweats or unexplained weight loss, or if you have been in close contact with someone who has active TB. Testing is also worth discussing before starting medicines that suppress the immune system or if you belong to a higher-risk group. During treatment, call your care team right away if you notice yellowing of the skin or eyes, stomach pain, nausea and vomiting, or a lasting loss of appetite, since these can signal liver injury from TB medicines. Also call promptly about new numbness or tingling in the hands or feet, dizziness or vision changes, and before stopping or skipping any medicine because of side effects.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tuberculosis is like, what's helped you, or ask the community a question.